Cerba Vet

Cerba Vet is a veterinary diagnostics business that provides laboratory services for animal health. Acquired by Mars, the company focuses on specialized diagnostic testing to support veterinary practices and advance animal care.

CCI Score

-27.13

0.01% April 18

Latest Event

Acquisition of Cerba Vet by Mars Petcare

Cerba Vet, a network of veterinary diagnostics laboratories in France, was acquired by Mars Petcare as part of its expansion in the veterinary diagnostics space, consolidating its market presence. The acquisition, announced on July 3, 2024, reflects the ongoing consolidation trends in the industry.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: CRISPR Therapeutics

Heska

Sinogene
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

ACCOMPLICE

Cerba Vet is currently rated as an Accomplice.

-20 to -29 CCI Score

These companies profit from authoritarian practices through their business dealings. Although they may not be directly enforcing oppressive policies, their actions contribute to the economic and operational sustenance of authoritarian regimes.

Latest Events

JUL

03

2024

Acquisition of Cerba Vet by Mars Petcare
-36.95

Cerba Vet, a network of veterinary diagnostics laboratories in France, was acquired by Mars Petcare as part of its expansion in the veterinary diagnostics space, consolidating its market presence. The acquisition, announced on July 3, 2024, reflects the ongoing consolidation trends in the industry.
-40

Economic and Structural Influence

March 29

The acquisition of Cerba Vet by Mars Petcare contributes to greater corporate consolidation and the concentration of economic power. This centralization of market control can further entrench oligarchic structures, which may undermine decentralized, democratic practices and enhance the risk of authoritarian influence. From an anti-fascist perspective, such consolidation is negative as it can erode accountability and reduce protections for smaller stakeholders.

Mars acquires two veterinary diagnostics businesses
JUL

02

2024

Mars Petcare Acquisition of Cerba Vet Raises Anti-Competitive Concerns
-50.00

A letter from Senators Warren and Blumenthal highlights how Mars Petcare’s acquisition of Cerba Vet, part of a decade-long consolidation in the veterinary industry, contributes to practices that inflate prices, degrade care quality, and worsen working conditions for veterinary staff.
MAY

03

2024

Mars Acquisition Talks for Cerba Vet and ANTAGENE
5.55

Mars Inc. has entered exclusive discussions with Cerba HealthCare to acquire Cerba Vet and ANTAGENE. The potential deal is subject to employee consultation and customary closing requirements, highlighting both a commitment to worker representation and raising concerns over increased corporate consolidation.
+15

Labor Relations and Human Rights Practices

March 29

The acquisition talks require consultation with employees and their representative bodies, which supports labor rights and worker input during a major corporate transition.

Mars Inc. in talks to buy Cerba Vet and ANTAGENE from Cerba HealthCare Group
-5

Economic Collaboration

March 29

The potential acquisition raises concerns about increased market consolidation, which can centralize economic power in a large conglomerate and potentially reduce market diversity and local autonomy.

Mars Inc. in talks to buy Cerba Vet and ANTAGENE from Cerba HealthCare Group